Genetics Access Pilot (GAP) Quality Improvement Project

Genetic Access Pilot (GAP) is a year long Quality Improvement project sponsored by the ACS Cancer Program launching January 2025. The project will engage up to 20 CoC and NAPBC accredited programs and seeks to better understand effective models for and barriers to offering genetic testing to newly diagnosed breast cancer patients.

The aim of this QI Pilot is to:

Increase the number of newly diagnosed breast cancer patients offered genetic testing by 20% from baseline at CoC/NAPBC pilot sites from January 2025 to December 2025.

The secondary outputs of this pilot project include:

• Obtain baseline data of genetic testing in pilot sites for proposed population
• Identify structural and process barriers to achieve testing
• Develop and test interventions to address modifiable barriers to genetic testing
• Spread, scale, and disseminate findings

Additional Resources

• GAP Initial Application (PDF only)
• GAP at a Glance Details
• GAP FAQ

Programs are encouraged to attend these webinars for more detailed information about the project. Attendance is requested by at least one member of each QI team, unless clinical care interferes Recordings and slides are available through the links below. Registration is required to listen to recorded webinars.

Informational Slides